Hyeong Ju Kwon

Phase II Clinical and Exploratory Biomarker Study of Dacomitinib in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of Head and Neck

Han Sang Kim, Hyeong Ju Kwon, Inkyung Jung et al. · Clinical Cancer Research · 2014 · 72 citations · Full text

Medicine, Oncology, Pharmacology +17

c‐Met‐mediated reactivation of PI3K/AKT signaling contributes to insensitivity of BRAF(V600E) mutant thyroid cancer to BRAF inhibition

Hyung Kwon Byeon, Hwi Jung Na, Yeon Ju Yang et al. · Molecular Carcinogenesis · 2015 · 59 citations · Full text

Medicine, Molecular Genetics, Oncology +17

The Use of the Bethesda System for Reporting Thyroid Cytopathology in Korea: A Nationwide Multicenter Survey by the Korean Society of Endocrine Pathologists

Mimi Kim, Hyo Jin Park, Hye Sook Min et al. · Journal of Pathology and Translational Medicine · 2017 · 36 citations · Full text

Medicine, Endocrinology, Pathology +17

Exome sequencing reveals recurrent REV3L mutations in cisplatin-resistant squamous cell carcinoma of head and neck

Kie Kyon Huang, Kang Won Jang, Sangwoo Kim et al. · Scientific Reports · 2016 · 28 citations · Full text

Medicine, Oncology, Pharmacology +17

The prevalence and surgical outcomes of Hürthle cell lesions in FNAs of the thyroid: A multi‐institutional study in 6 Asian countries

Shipra Agarwal, Andrey Bychkov, Chan Kwon Jung et al. · Cancer Cytopathology · 2019 · 27 citations · Full text

Medicine, Oncology, Pathology +17